159 related articles for article (PubMed ID: 599839)
1. Renal vascular response to interruption of the renin-angiotensin system in normal man.
Hollenberg NK; Williams GH; Taub KJ; Ishikawa I; Brown C; Adams DF
Kidney Int; 1977 Oct; 12(4):285-93. PubMed ID: 599839
[TBL] [Abstract][Full Text] [Related]
2. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
3. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
MacGregor GA; Dawes PM
Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
[TBL] [Abstract][Full Text] [Related]
5. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
Williams GH; Hollenberg NK
N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
[TBL] [Abstract][Full Text] [Related]
6. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
[TBL] [Abstract][Full Text] [Related]
7. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
Hollenberg NK; Williams GH; Burger B; Ishikawa I; Adams DF
J Clin Invest; 1976 Jan; 57(1):39-46. PubMed ID: 1245602
[TBL] [Abstract][Full Text] [Related]
8. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
9. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
Bing J; Poulsen K
Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
[TBL] [Abstract][Full Text] [Related]
10. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
11. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
Harris PJ; Munro JO
J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
[TBL] [Abstract][Full Text] [Related]
13. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
[TBL] [Abstract][Full Text] [Related]
14. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
McGrath BP; Ledingham JG; Benedict CR
Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
[TBL] [Abstract][Full Text] [Related]
15. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
Liang CS; Gavras H; Hood WB
J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
[TBL] [Abstract][Full Text] [Related]
19. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
[TBL] [Abstract][Full Text] [Related]
20. The adrenal receptor for angiotensin II is altered in essential hypertension.
Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
